Takeda halts trial of orexin drug in narcolepsy on safety groundsJapanese drugmaker Takeda has suspended dosing in phase 2 trials of its orexin agonist TAK-994, saying it had Share XTakeda halts trial of orexin drug in narcolepsy on safety groundshttps://pharmaphorum.com/news/takeda-halts-trial-of-orexin-drug-in-narcolepsy-on-safety-grounds/
